Photo by bermixstudio from unsplash
Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy. Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy. Click to show full abstract
Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy. Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy.
Keywords:
timing matters;
combination therapy;
matters combination
Journal Title: Science Signaling
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Science Signaling
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!